By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – eBioscience and Australian firm Anteo Diagnostics today announced a licensing deal covering Anteo's Mix&Go technology.

Anteo will supply eBioscience with its Mix&Go product for the manufacture of reagents. In return it will receive an initial upfront payment from eBioscience, fixed revenues for Mix&Go reagents supplied, and royalties on the sale of products by eBioscience using Mix&Go.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.